These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26338686)

  • 21. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study.
    Richy FF; Sabidó-Espin M; Guedes S; Corvino FA; Gottwald-Hostalek U
    Diabetes Care; 2014 Aug; 37(8):2291-5. PubMed ID: 24879835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study.
    Kaewput W; Thongprayoon C; Chewcharat A; Rangsin R; Satirapoj B; Kaewput C; Suwannahitatorn P; Bathini T; Mao MA; Cato LD; Harrison AM; Vaitla P; Cheungpasitporn W
    Ther Apher Dial; 2020 Dec; 24(6):677-687. PubMed ID: 31997551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study.
    Spanopoulos D; Okhai H; Zaccardi F; Tebboth A; Barrett B; Busse M; Webb J; Khunti K
    Diabetes Obes Metab; 2019 Aug; 21(8):1817-1823. PubMed ID: 30941882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
    Lachin JM; Viberti G; Zinman B; Haffner SM; Aftring RP; Paul G; Kravitz BG; Herman WH; Holman RR; Kahn SE;
    Clin J Am Soc Nephrol; 2011 May; 6(5):1032-40. PubMed ID: 21454723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study.
    Whitlock RH; Hougen I; Komenda P; Rigatto C; Clemens KK; Tangri N
    Mayo Clin Proc; 2020 Jan; 95(1):90-100. PubMed ID: 31902433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unleash metformin: reconsideration of the contraindication in patients with renal impairment.
    Lu WR; Defilippi J; Braun A
    Ann Pharmacother; 2013 Nov; 47(11):1488-97. PubMed ID: 24259604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular Drugs and Metformin Drug Dosage According to Renal Function in Non-Institutionalized Elderly Patients.
    Becquemont L; Bauduceau B; Benattar-Zibi L; Al-Salameh A; Berrut G; Bertin P; Bucher S; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Pasquier F; Pinget M; Ourabah R; Piedvache C
    Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):468-73. PubMed ID: 26573791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.
    van Dalem J; Brouwers MC; Stehouwer CD; Krings A; Leufkens HG; Driessen JH; de Vries F; Burden AM
    BMJ; 2016 Jul; 354():i3625. PubMed ID: 27413017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study.
    Mor A; Petersen I; Sørensen HT; Thomsen RW
    BMJ Open; 2016 Aug; 6(8):e011523. PubMed ID: 27543589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and Risk Factors Associated with Outpatient Hypoglycemia in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Study.
    Kaewput W; Thongprayoon C; Rangsin R; Bathini T; Torres-Ortiz A; Mao MA; Cheungpasitporn W
    Endocr Res; 2020 Nov; 45(4):217-225. PubMed ID: 32662297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin: time to review its role and safety in chronic kidney disease.
    Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI
    Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
    Iwase M; Ide H; Ohkuma T; Fujii H; Komorita Y; Yoshinari M; Oku Y; Higashi T; Nakamura U; Kitazono T
    Clin Exp Nephrol; 2022 Feb; 26(2):122-131. PubMed ID: 34581896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
    Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
    Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing pragmatic estimated GFR thresholds to guide metformin prescribing.
    Shaw JS; Wilmot RL; Kilpatrick ES
    Diabet Med; 2007 Oct; 24(10):1160-3. PubMed ID: 17672860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic kidney disease in type 2 diabetes: lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study.
    Pugliese G; Solini A; Bonora E; Fondelli C; Orsi E; Nicolucci A; Penno G;
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):815-22. PubMed ID: 24780515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.